Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1204P (RNA, U6 small nuclear 1204, pseudogene) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene, part of a large family of non-coding snRNA genes in the human genome[4][5][6]. U6 snRNA is a component of the spliceosome, crucial for pre-mRNA splicing and post-transcriptional modification[1][3]. However, RNU6-1204P itself does not encode a functional RNA or protein and is a nonfunctional genomic remnant arising from retrotransposition events mediated by LINE-1 elements[6]. Such pseudogenes are signatures of genome evolution and do not participate in biological processes, therapeutic mechanisms, or disease pathways. U6 snRNA pseudogenes are highly prevalent in vertebrate genomes and serve as markers for retrotransposition dynamics, especially those mediated by LINE-1 elements[6]. The parental U6 snRNA plays a crucial role in the catalytic activity of the spliceosome for intron removal, but its pseudogene copies, including RNU6-1204P, do not retain this function[1][3][6]. Expression data show presence in various tissues (e.g., dorsolateral prefrontal cortex, monocyte, colon), but this reflects transcriptional noise or genomic context rather than functional output[5]. No evidence exists to support this pseudogene as a receptor, enzyme, transcription factor, or transporter. This entry should primarily be used to annotate genomic structural variants or retrotransposition studies, not for therapeutic targeting or biomarker applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1204, pseudogene (RNU6-1204P).